Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stephan Faderl
Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities
Cancer
Cancer Research
Oncology
Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia
Acta Haematologica Polonica
Oncology
Hematology
A Phase II Study of Omacetaxine Mepesuccinate for Patients With Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia After Failure of Hypomethylating Agents
American Journal of Hematology
Hematology
Therapy-Related Myelodysplastic Syndrome-Acute Myelogenous Leukemia in Patients Treated for Acute Promyelocytic Leukemia: An Emerging Problem
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Upregulation of Mir-99a Is Associated With Poor Prognosis of Acute Myeloid Leukemia and Promotes Myeloid Leukemia Cell Expansion
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Autologous Stem Cell Transplantation for Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Biologic Characteristics of Acute Leukemia After Myelodysplastic Syndrome
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes
Seminars in Oncology
Oncology
Hematology
